COBAS TAQMAN 48 ANALYZER

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2010-12-08 for COBAS TAQMAN 48 ANALYZER manufactured by Roche Diagnostics Ltd..

Event Text Entries

[1654058] A customer in (b)(6) reported that they received a false (b)(6) result for a patient sample while using the kit c-taq hbv 48 tests expt-ivd ce (p/n 03300756190; lot unknown) with amplilink software v. 3. 2. 2. The result that the software reported was (b)(6). However, the fluorescence amplification curve shows that the sample had (b)(6). When the sample was re-run, the titer was (b)(6). The result from the initial run (b)(6) was not reported. The result of (b)(6) was reported. Patient treatment was not affected.
Patient Sequence No: 1, Text Type: D, B5


[8907878] This issue is currently under investigation. No conclusions can be drawn at this time. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[9125870] (b)(4). Computer software performance tests conducted, algorithm analysis, software / firmware caused event, unusual event. The investigation determined that the discrepant target not detected (tnd) result was caused by the baseline normalization calculation of the elth algorithm. In very rare instances, the analysis curves of the affected samples are noisy in the first few cycles. The (b)(4) curves did not have enough valid baseline points for a correct calculation of the baseline. Therefore, the data points of the plateau region were incorrectly used for the calculation of the baseline, leading to an incorrect tnd result. All affected roche molecular systems assays were assessed for risks and possible impacts due to the elth baseline normalization anomaly. All potential failure modes were analyzed. The anomaly has an extremely low rate of occurrence. (b)(4). All residual risks identified were determined to be in the acceptable or alarp (as low as reasonably practical) range. The overall residual risk was determined to be acceptable with no major impact on assay or system performance expected. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2010-00046
MDR Report Key1916848
Report Source01,05
Date Received2010-12-08
Date of Report2010-11-23
Date of Event2010-11-23
Date Mfgr Received2010-11-23
Date Added to Maude2012-01-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS TAQMAN 48 ANALYZER
Generic NameANALYZER, CHEMISTRY, MICRO, FOR CLINICAL USE
Product CodeJJF
Date Received2010-12-08
ID NumberAMPLILINK SOFTWARE V.3.2.2
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS LTD.
Manufacturer AddressFORRENSTRASSE ROTKREUZ, ZUG CH-6343 SZ CH-6343 S


Patients

Patient NumberTreatmentOutcomeDate
10 2010-12-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.